AWM
COGT icon

Avior Wealth Management’s Cogent Biosciences COGT Stock Holding History

Avior Wealth Management’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-16
Closed -$107 – 2568
2024
Q1 		$107 Buy
+16
New +$99 ﹤0.01% 3158

Other funds holding COGT

Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Avior Wealth Management's COGT Position: Q2 2024 in Review

Avior Wealth Management sold out of Cogent Biosciences (COGT) in Q2 2024, closing a stake of 16 shares — an estimated $107 sold.

Avior Wealth Management first reported a position in COGT in Q1 2024 and held it in 1 quarter. The position peaked at $107 in Q1 2024. 148 funds tracked by Wall St. Rank hold COGT as of Q2 2024.

  • Avior Wealth Management reported no remaining Cogent Biosciences position as of Q2 2024 after selling out during the quarter.
  • Avior Wealth Management sold 16 Cogent Biosciences shares in Q2 2024, an estimated $107.
  • Avior Wealth Management first reported a position in Cogent Biosciences in Q1 2024 and held it in 1 quarter.
  • Avior Wealth Management's Cogent Biosciences position peaked at $107 in Q1 2024.
  • 148 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2024.

Based on Avior Wealth Management's 13F filing for Q2 2024, filed 13 Aug 2024.